+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopharmaceutical Bioseparation Systems Market by Product Type, Application, End User, Operation Mode - Global Forecast to 2030- Product Image
Biopharmaceutical Bioseparation Systems Market by Product Type, Application, End User, Operation Mode - Global Forecast to 2030- Product Image
Sale

Biopharmaceutical Bioseparation Systems Market by Product Type, Application, End User, Operation Mode - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010879
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biopharmaceutical Bioseparation Systems Market is entering a pivotal phase as advanced purification technologies, regulatory changes, and global supply chain pressures reshape how biologics are produced and delivered. As sector complexity grows, senior leaders must navigate shifting demands with agility and focus on operational resilience.

Market Snapshot: Biopharmaceutical Bioseparation Systems

The biopharmaceutical bioseparation systems market expanded from USD 16.48 billion in 2024 to USD 18.09 billion in 2025 and is projected to reach USD 28.52 billion by 2030, reflecting a 9.56% CAGR. This rapid acceleration underscores transformative innovation in downstream processing, fueled by heightened demand for efficient purification in areas such as monoclonal antibodies, vaccines, and recombinant proteins. Competitive dynamics are intensifying as leading global players and emerging challengers invest heavily in technology, supply chain security, and regulatory readiness.

Scope & Segmentation

This comprehensive research assesses the breadth and depth of the bioseparation market, providing granular insights across applications, users, and technologies. Key segmentation includes:

  • Product Types: Centrifugation systems (decanter, disc stack, tubular bowl), chromatography systems (affinity, hydrophobic interaction, ion exchange, mixed-mode, size exclusion), membrane filtration (microfiltration, nanofiltration, ultrafiltration), and single-use systems for chromatography and filtration.
  • Applications: Cell clarification, polishing and final purification, protein purification (enzymes, monoclonal antibodies, peptides, recombinant proteins), vaccine production, virus purification.
  • End Users: Academic and research institutes, biopharmaceutical companies, bioservices providers, contract manufacturing organizations.
  • Operation Modes: Batch processing and continuous processing, including multi-column chromatography and perfusion workflows.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (notably UK, Germany, France, UAE, Saudi Arabia, South Africa, and more), Asia-Pacific (China, India, Japan, Australia, South Korea, and others).
  • Key Players: Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius AG, Merck KGaA, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Waters Corporation, Repligen Corporation, Eppendorf AG, Tecan Group Ltd.

Key Takeaways: Innovation and Decision Imperatives

  • Process intensification strategies, such as continuous downstream systems and digital analytics, are increasingly central to operational models, enabling higher consistency and throughput in biologics manufacturing.
  • Single-use platforms and modular purification units are driving greater flexibility and rapid adaptation to varying product pipelines, supporting faster campaign turnovers and minimizing cross-contamination risks.
  • Adoption of hybrid chromatographic-membrane technologies is increasing as stakeholders seek to optimize yields and minimize environmental impact in pursuit of sustainable growth objectives.
  • Regional distribution patterns highlight that localized investments in infrastructure and targeted workforce training accelerate the adoption of advanced bioseparation solutions in high-growth markets.
  • Strategic collaborations, acquisitions, and R&D initiatives are reshaping supplier capabilities, resulting in expanded product portfolios and enhanced customer support for specialized separation challenges.

Tariff Impact on Bioseparation Supply Chains

The introduction of new U.S. tariffs in 2025 on separation media, consumables, and equipment has led to increased costs and heightened supply chain complexity. Manufacturers are responding by sourcing domestic alternatives, renegotiating supplier agreements, and reevaluating operational lifecycles. These measures, while mitigating short-term disruptions, require continuous alignment with validation and regulatory standards. Over time, regional manufacturing strategies and supply chain diversification are expected to support long-term resilience in bioprocessing operations.

Methodology & Data Sources

This report synthesizes secondary research from peer-reviewed journals, white papers, and patent databases with primary insights from senior executives, engineers, and procurement specialists. Quantitative modeling integrates shipment data, facility expansions, and historical market trends, validated through sensitivity analyses of factors such as tariff effects and capacity shifts.

Why This Report Matters

  • Actionable market segments and emerging trend analysis empower decision-makers to refine investment and procurement strategies in a rapidly changing bioseparation environment.
  • Region-specific intelligence supports the formulation of targeted deployment and compliance plans, ensuring alignment with regulatory requirements and market entry conditions.
  • Detailed competitive profiles and supply chain impact assessments help organizations strengthen resilience and identify collaboration or acquisition opportunities.

Conclusion

The bioseparation systems market is moving toward more adaptive, digitally integrated, and regionally diversified solutions. Leaders who anticipate regulatory changes, invest in workforce development, and leverage process innovation will be well-positioned as the landscape evolves.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biopharmaceutical Bioseparation Systems Market, by Product Type
8.1. Introduction
8.2. Centrifugation Systems
8.2.1. Decanter Centrifuge Systems
8.2.2. Disc Stack Centrifuge Systems
8.2.3. Tubular Bowl Centrifuge Systems
8.3. Chromatography Systems
8.3.1. Affinity Chromatography
8.3.1.1. Immobilized Metal Affinity Chromatography
8.3.1.2. Lectin Affinity Chromatography
8.3.1.3. Protein A Affinity Chromatography
8.3.2. Hydrophobic Interaction Chromatography
8.3.3. Ion Exchange Chromatography
8.3.4. Mixed-Mode Chromatography
8.3.5. Size Exclusion Chromatography
8.4. Membrane Filtration Systems
8.4.1. Microfiltration Systems
8.4.2. Nanofiltration Systems
8.4.3. Ultrafiltration Systems
8.5. Single-Use Systems
8.5.1. Single-Use Chromatography Systems
8.5.2. Single-Use Filtration Systems
9. Biopharmaceutical Bioseparation Systems Market, by Application
9.1. Introduction
9.2. Cell Clarification
9.3. Polishing & Final Purification
9.4. Protein Purification
9.4.1. Enzyme Purification
9.4.2. Monoclonal Antibodies
9.4.3. Peptide Purification
9.4.4. Recombinant Protein Purification
9.5. Vaccine Production
9.6. Virus Purification
10. Biopharmaceutical Bioseparation Systems Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Biopharmaceutical Companies
10.4. Bioservices
10.5. Contract Manufacturing Organizations
11. Biopharmaceutical Bioseparation Systems Market, by Operation Mode
11.1. Introduction
11.2. Batch Processing
11.3. Continuous Processing
11.3.1. Multi-Column Chromatography
11.3.2. Perfusion Processing
12. Americas Biopharmaceutical Bioseparation Systems Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biopharmaceutical Bioseparation Systems Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biopharmaceutical Bioseparation Systems Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Danaher Corporation
15.3.3. Sartorius AG
15.3.4. Merck KGaA
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Agilent Technologies, Inc.
15.3.7. Waters Corporation
15.3.8. Repligen Corporation
15.3.9. Eppendorf AG
15.3.10. Tecan Group Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET MULTI-CURRENCY
FIGURE 2. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET MULTI-LANGUAGE
FIGURE 3. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY DECANTER CENTRIFUGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY DISC STACK CENTRIFUGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY TUBULAR BOWL CENTRIFUGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY LECTIN AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN A AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY HYDROPHOBIC INTERACTION CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ION EXCHANGE CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MIXED-MODE CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SIZE EXCLUSION CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MICROFILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY NANOFILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ULTRAFILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE FILTRATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CELL CLARIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY POLISHING & FINAL PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ENZYME PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PEPTIDE PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY RECOMBINANT PROTEIN PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY VIRUS PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BIOSERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY BATCH PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MULTI-COLUMN CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PERFUSION PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 83. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 84. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 86. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 88. CANADA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 134. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 145. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 147. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 148. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 149. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 151. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 153. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 156. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 158. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 159. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 160. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 161. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 162. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 164. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 166. FRANCE BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 167. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 178. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 180. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 181. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 182. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 183. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 184. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 186. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 188. ITALY BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 189. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 191. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 192. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 193. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 194. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 195. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 197. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 199. SPAIN BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 200. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 222. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 233. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 235. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 237. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 238. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 239. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 241. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 243. DENMARK BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 244. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 252. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 255. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 257. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 258. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 259. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 260. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 261. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 263. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY OPERATION MODE, 2018-2030 (USD MILLION)
TABLE 265. QATAR BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CONTINUOUS PROCESSING, 2018-2030 (USD MILLION)
TABLE 266. FINLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. FINLAND BIOPHARMACEUTICAL BIOSEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 268. FINLAND BIOPHARMACEUTICAL BIOSEP

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biopharmaceutical Bioseparation Systems market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Sartorius AG
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Waters Corporation
  • Repligen Corporation
  • Eppendorf AG
  • Tecan Group Ltd.

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 18.09 Billion
Forecasted Market Value ( USD ) by 2030 $ 28.52 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biopharmaceutical Bioseparation Systems - Global Strategic Business Report - Product Image

Biopharmaceutical Bioseparation Systems - Global Strategic Business Report

  • Report
  • 360 Pages
  • Global
From
Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type, Testing Type, Technology, Application, End User - Global Forecast to 2030 - Product Image

Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type, Testing Type, Technology, Application, End User - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Biopharmaceutical Process Analytical Technology Market by Technology, Process Stage, Product Type, Deployment, End User, Application, Scale - Global Forecast to 2030 - Product Image

Biopharmaceutical Process Analytical Technology Market by Technology, Process Stage, Product Type, Deployment, End User, Application, Scale - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Hollow Fiber Filtration - Global Strategic Business Report - Product Image

Hollow Fiber Filtration - Global Strategic Business Report

  • Report
  • 244 Pages
  • Global
From
Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type, Application - Global Forecast to 2031 - Product Image

Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type, Application - Global Forecast to 2031

  • Report
  • 294 Pages
  • Global
From

About the Market

In biotechnology, bioseparation systems are crucial for the purification and analysis of bio-molecules such as proteins, DNA, and antibodies that are used in various biopharmaceutical applications. These systems employ a range of techniques like chromatography, centrifugation, filtration, and electrophoresis to isolate specific biological components from complex mixtures. The demand for these systems is driven by the need for therapeutically and diagnostically relevant biomolecules with high purity and yield. The field is marked by continuous advancement to enhance efficiency, scalability, and cost-effectiveness and to cater to the stringent regulatory standards for biopharmaceutical production. Innovations in the domain often revolve around improving selectivity and reducing processing time. Some notable players in the biopharmaceutical bioseparation systems market include GE Healthcare (now part of Danaher Corporation), Merck KGaA, Thermo Fisher Scientific, and Sartorius Stedim Biotech. These companies provide a range of bioseparation products and services, helping to drive advancements in the preparation of biological products. Each company typically engages in research and development to bring forward innovations in separation technologies that aim to meet the evolving needs of the biopharmaceutical industry. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.